Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings

Journal of Infectious Diseases

Volumn 205, Issue 9, 2012, Pages 1336-1341

  Viner, Kendra ^a   Perella, Dana ^a   Lopez, Adriana ^b   Bialek, Stephanie ^b   Newbern, Claire ^a   Pierre, Rodrerica ^a   Spells, Niya ^a   Watson, Barbara ^a  

^a PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHICKENPOX; DAY CARE; DISEASE SEVERITY; HERPES ZOSTER; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; RISK FACTOR; SECONDARY INFECTION; UNITED STATES; VARICELLA ZOSTER VIRUS; VIRUS TRANSMISSION;

CHICKENPOX; CHILD; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INCIDENCE; PHILADELPHIA; RETROSPECTIVE STUDIES; RISK FACTORS; SCHOOLS; VACCINATION;

EID: 84861561456     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis207     Document Type: Article

References (14)

1. Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc 2009; 84:274-80.
2. Josephson A, Gombert ME. Airborne transmission of nosocomial varicella from localized zoster. J Infect Dis 1988; 158:238-41.
3. Leclair JM, Zaia JA, Levin MJ, Congdon RG, Goldmann DA. Airborne transmission of chickenpox in a hospital. N Engl J Med 1980; 302: 450-3.
4. Lopez AS, Burnett-Hartman A, Nambiar R, et al. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 2008; 197:646-53.
5. Suzuki K, Yoshikawa T, Tomitaka A, Matsunaga K, Asano Y. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis 2004; 189:1009-12.
6. Leung J, Harpaz R, Baughman AL, et al. Evaluation of laboratory methods for diagnosis of varicella. Clin Infect Dis 2010; 51:23-32.
7. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35: S65-164.
8. Barker L, Santoli J, McCauley M. National, state, and urban area vaccination coverage among children aged 19-35 months-United States, 2004. MMWR Morb Mortal Wkly Rep 2005; 54:717-21.
9. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005; 352:450-8.
10. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287:606-11.
11. Civen R, Chaves SS, Jumaan A, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 2009; 28: 954-9.
12. Averhoff F, Zimmerman L, Harpaz R, Guris D, Rue A. Varicella surveillance practicesdUnited States, 2004. MMWR Morb Mortal Wkly Rep 2006; 55:1126-9.
13. Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol 2000; 38:4315-19.
14. Suzuki K, Yoshikawa T, Tomitaka A, Suzuki K, Matsunaga K, Asano Y. Detection of varicella-zoster virus DNA in throat swabs of patients with herpes zoster and on air purifier filters. J Med Virol 2002; 66: 567-70.